相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nanomedicinal strategies as efficient therapeutic interventions for delivery of cancer vaccines
Sarwar Beg et al.
SEMINARS IN CANCER BIOLOGY (2021)
Advances of functional nanomaterials for cancer immunotherapeutic applications
Yuhao Hao et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2020)
Emerging Prospects for Nanoparticle-Enabled Cancer Immunotherapy
Manal Ali Buabeid et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
Evaluation of bilosomes as nanocarriers for transdermal delivery of tizanidine hydrochloride: in vitro and ex vivo optimization
Rawia M. Khalil et al.
JOURNAL OF LIPOSOME RESEARCH (2019)
A journey through the emergence of nanomedicines with poly(alkylcyanoacrylate) based nanoparticles
Christine Vauthier
JOURNAL OF DRUG TARGETING (2019)
Nanoparticle systems for cancer vaccine
Ru Wen et al.
NANOMEDICINE (2019)
Nanoparticle-Based Nanomedicines to Promote Cancer Immunotherapy: Recent Advances and Future Directions
Jianping Liu et al.
SMALL (2019)
Chitosan and chitosan coating nanoparticles for the treatment of brain disease
Shuangwen Yu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Pichia pastoris-expressed Zika virus envelope domain III on a virus-like particle platform: design, production and immunological evaluation
Rajgokul K. Shanmugam et al.
PATHOGENS AND DISEASE (2019)
Nanovaccines for cancer immunotherapy
Yu Zhang et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2019)
Bioinspired and Biomimetic Nanotherapies for the Treatment of Infectious Diseases
Guoyu Yang et al.
FRONTIERS IN PHARMACOLOGY (2019)
Recent Advances in Nanovaccines Using Biomimetic Immunomodulatory Materials
Veena Vijayan et al.
PHARMACEUTICS (2019)
Protein-based nanoparticles in cancer vaccine development
Medea Neek et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
In Situ Dendritic Cell Vaccine for Effective Cancer Immunotherapy
Weijing Yang et al.
ACS NANO (2019)
Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy
Pingsheng Huang et al.
ACTA BIOMATERIALIA (2019)
Combined Skin and Muscle DNA Priming Provides Enhanced Humoral Responses to a Human Immunodeficency Virus Type 1 Clade C Envelope Vaccine
Hannah Mary Cheeseman et al.
HUMAN GENE THERAPY (2018)
Design and immunological evaluation of anti-CD205-tailored PLGA-based nanoparticulate cancer vaccine
Sheikh Tasnim Jahan et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Iron Oxide Nanoparticles-Based Vaccine Delivery for Cancer Treatment
Yi Zhao et al.
MOLECULAR PHARMACEUTICS (2018)
Niosomes, an alternative for liposomal delivery
Rianne Bartelds et al.
PLOS ONE (2018)
Spray-Dried Nanoparticle-in-Microparticle Delivery Systems (NiMDS) for Gene Delivery, Comprising Polyethylenimine (PEI)-Based Nanoparticles in a Poly(Vinyl Alcohol) Matrix
Jan Schulze et al.
SMALL (2018)
3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection
A. M. Ortega-Prieto et al.
NATURE COMMUNICATIONS (2018)
Adjuvanted influenza vaccines
John S. Tregoning et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Lipid-Based Particles: versatile Delivery Systems for Mucosal vaccination against infection
Blaise Corthesy et al.
FRONTIERS IN IMMUNOLOGY (2018)
Nanomedicine: Principles, Properties, and Regulatory Issues
Sara Soares et al.
FRONTIERS IN CHEMISTRY (2018)
Biomaterials for vaccine-based cancer immunotherapy
Rui Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Recent advancement in nanocarriers for oral vaccination
Preeti Kour et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Cross-Protective Shigella Whole-Cell Vaccine With a Truncated O-Polysaccharide Chain
Min Jung Kim et al.
FRONTIERS IN MICROBIOLOGY (2018)
Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care
Christopher M. Hartshorn et al.
ACS NANO (2018)
Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures
Heloise Ragelle et al.
EXPERT OPINION ON DRUG DELIVERY (2017)
The effect of particle shape on cellular interaction and drug delivery applications of micro-and nanoparticles
Anil B. Jindal
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
An immunoinformatics approach to promiscuous peptide design for the Plasmodium falciparum erythrocyte membrane protein-1
Nazam Khan et al.
MOLECULAR BIOSYSTEMS (2017)
Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer
Charles B. Chesson et al.
NANOMEDICINE (2017)
Major findings and recent advances in virus like particle (VLP)-based vaccines
Mona O. Mohsen et al.
SEMINARS IN IMMUNOLOGY (2017)
Liposomal-Based Therapeutic Carriers for Vaccine and Gene Delivery
Mahfoozur Rahman et al.
NANOTECHNOLOGY-BASED APPROACHES FOR TARGETING AND DELIVERY OF DRUGS AND GENES (2017)
A phase 1, open-label, randomized study to compare the immunogenicity and safety of different administration routes and doses of virosomal influenza vaccine in elderly
Yotam Levin et al.
VACCINE (2016)
Nanomedicine-Mediated Therapies to Target Breast Cancer Stem Cells
Lili He et al.
FRONTIERS IN PHARMACOLOGY (2016)
Mucosal Vaccine Development Based on Liposome Technology
Valentina Bernasconi et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Invasion and metastasis-recent advances and future challenges
Ann F. Chambers et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2015)
Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents
Jing Zhao et al.
NANOMEDICINE (2015)
Colloidal Drug Delivery Systems in Vaccine Delivery
Sarwar Beg et al.
CURRENT DRUG TARGETS (2013)
Challenges in Development of Nanoparticle-Based Therapeutics
Neil Desai
AAPS JOURNAL (2012)
Significant systemic and mucosal immune response induced on oral delivery of diphtheria toxoid using nano-bilosomes
Anshuman Shukla et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations
Marco Tamborrini et al.
MALARIA JOURNAL (2011)
Immunotherapy of Cancer: Key Findings and Commentary on the Third Tegernsee Conference
Dominik Ruttinger et al.
ONCOLOGIST (2010)
Epaxal®: a virosomal vaccine to prevent hepatitis A infection
Patrick A. Bovier
EXPERT REVIEW OF VACCINES (2008)
Immune Augmentation of Single Contact Hepatitis B Vaccine by Using PLGA Microspheres as an Adjuvant
S. M. Sivakumar et al.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles
H Shen et al.
IMMUNOLOGY (2006)
Lipid based particulate formulations for the delivery of antigen
MJ Copland et al.
IMMUNOLOGY AND CELL BIOLOGY (2005)
Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX™ adjuvant in women with cervical intraepithelial neoplasia
IH Frazer et al.
VACCINE (2004)
Vaccines administered simultaneously: directions for new combination vaccines based on an historical review of the literature
MA Fletcher et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2004)
A review of combined hepatitis A and hepatitis B vaccination for travelers
AM Spira
CLINICAL THERAPEUTICS (2003)
Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma
A Ito et al.
CANCER SCIENCE (2003)
Recombinant hepatitis B vaccine (Engerix-B (R)) - A review of its immunogenicity and protective efficacy against hepatitis B
GM Keating et al.
DRUGS (2003)
Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes)
M Conacher et al.
VACCINE (2001)
分享论文
